Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer

NCT00735696

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Beverly Hills, California, United States
  • ImClone Investigational Site San Francisco, California, United States
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site New York, United States
View Trial Details
Completed

Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

NCT01700400

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Arizona Cancer Center Tuscon, Arizona, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
  • Providence Cancer Center Portland, Oregon, United States
  • Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States
View Trial Details
Completed

MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer

NCT00799240

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Hutchinson Clinic, PA Hutchinson, Kansas, United States
  • Kansas University Cancer Center Kansas City, Kansas, United States
  • Stormont Vail Healthcare Topeka, Kansas, United States
  • VA Medical Center Kansas City, Missouri, United States
View Trial Details
Completed

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

NCT01934465

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Hospital of Crete, Dep of Medical Oncology Heraklion, Crete, Greece
  • University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupoli, Greece
  • "IASO" General Hospital of Athens Athens, Greece
  • 401 Military Hospital of Athens Athens, Greece
View Trial Details
Completed

A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

NCT01031225

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Cancer Center; University of Arizona Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Health System Santa Monica, California, United States
View all 21 locations
View Trial Details
Completed

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

NCT00620971

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
View Trial Details
Completed

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

NCT00879866

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
  • Department of Pulmonology, Academic Hosptial Maastricht Masstricht, Netherlands
  • Department of Medical Oncology (452), Radboud UMC Nijmegen Nijmegen, Netherlands
View Trial Details

Related conditions